167 related articles for article (PubMed ID: 34864837)
1. Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia In Situ, and Germ Cell Tumors of the Testis.
Ricci C; Franceschini T; Giunchi F; Grillini M; Ambrosi F; Massari F; Mollica V; Colecchia M; Fiorentino M
Am J Clin Pathol; 2022 May; 157(5):644-648. PubMed ID: 34864837
[TBL] [Abstract][Full Text] [Related]
2. SOX2 and PRAME in the "reprogramming" of seminoma cells.
Orsatti A; Sirolli M; Ambrosi F; Franceschini T; Giunchi F; Franchini E; Grillini M; Massari F; Mollica V; Bianchi FM; Colecchia M; Fiorentino M; Ricci C
Pathol Res Pract; 2022 Sep; 237():154044. PubMed ID: 35930824
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17.
Zhou Y; Rothrock A; Murugan P; Li F; Bu L
Exp Mol Pathol; 2022 Jun; 126():104761. PubMed ID: 35390309
[TBL] [Abstract][Full Text] [Related]
4. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
[TBL] [Abstract][Full Text] [Related]
5. Seminoma component of mixed testicular germ cell tumor shows a higher incidence of loss of heterozygosity than pure-type seminoma.
Miyai K; Ito K; Nakanishi K; Tsuda H
Hum Pathol; 2019 Feb; 84():71-80. PubMed ID: 30266250
[TBL] [Abstract][Full Text] [Related]
6. Testicular Tumors: A Contemporary Update on Morphologic, Immunohistochemical and Molecular Features.
Al-Obaidy KI; Idrees MT
Adv Anat Pathol; 2021 Jul; 28(4):258-275. PubMed ID: 33871428
[TBL] [Abstract][Full Text] [Related]
7. Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas.
Chen YT; Cao D; Chiu R; Lee P
Cancer Immun; 2013; 13():10. PubMed ID: 23885216
[TBL] [Abstract][Full Text] [Related]
8. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
[TBL] [Abstract][Full Text] [Related]
9. Specific immune cell and cytokine characteristics of human testicular germ cell neoplasia.
Klein B; Haggeney T; Fietz D; Indumathy S; Loveland KL; Hedger M; Kliesch S; Weidner W; Bergmann M; Schuppe HC
Hum Reprod; 2016 Oct; 31(10):2192-202. PubMed ID: 27609978
[TBL] [Abstract][Full Text] [Related]
10. On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitro.
Fink C; Baal N; Wilhelm J; Sarode P; Weigel R; Schumacher V; Nettersheim D; Schorle H; Schröck C; Bergmann M; Kliesch S; Kressin M; Savai R
Neoplasia; 2021 Jul; 23(7):731-742. PubMed ID: 34153645
[TBL] [Abstract][Full Text] [Related]
11. Activin A target genes are differentially expressed between normal and neoplastic adult human testes: clues to gonocyte fate choice.
Szarek M; Bergmann M; Konrad L; Schuppe HC; Kliesch S; Hedger MP; Loveland KL
Andrology; 2019 Jan; 7(1):31-41. PubMed ID: 30315637
[TBL] [Abstract][Full Text] [Related]
12. Association of intratubular seminoma and intratubular embryonal carcinoma with invasive testicular germ cell tumors.
Lau SK; Weiss LM; Chu PG
Am J Surg Pathol; 2007 Jul; 31(7):1045-9. PubMed ID: 17592271
[TBL] [Abstract][Full Text] [Related]
13. TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis.
Melotti S; Ambrosi F; Franceschini T; Giunchi F; Filippo GD; Franchini E; Massari F; Mollica V; Tateo V; Bianchi FM; Colecchia M; Acosta AM; Lobo J; Fiorentino M; Ricci C
Pathol Res Pract; 2023 Jul; 247():154540. PubMed ID: 37209574
[TBL] [Abstract][Full Text] [Related]
14. Pagetoid spread into the rete testis by testicular tumours.
Lee AH; Theaker JM
Histopathology; 1994 Apr; 24(4):385-9. PubMed ID: 8045529
[TBL] [Abstract][Full Text] [Related]
15. Cancer testis antigen expression in testicular germ cell tumorigenesis.
Bode PK; Thielken A; Brandt S; Barghorn A; Lohe B; Knuth A; Moch H
Mod Pathol; 2014 Jun; 27(6):899-905. PubMed ID: 24232866
[TBL] [Abstract][Full Text] [Related]
16. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
[TBL] [Abstract][Full Text] [Related]
17. The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors.
Kawakami T; Okamoto K; Sugihara H; Hattori T; Reeve AE; Ogawa O; Okada Y
J Urol; 2003 Apr; 169(4):1546-52. PubMed ID: 12629412
[TBL] [Abstract][Full Text] [Related]
18. CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.
Oz Atalay F; Aytac Vuruskan B; Vuruskan H
J Int Med Res; 2016 Dec; 44(6):1323-1330. PubMed ID: 28322096
[TBL] [Abstract][Full Text] [Related]
19. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
20. Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors.
Netto GJ; Nakai Y; Nakayama M; Jadallah S; Toubaji A; Nonomura N; Albadine R; Hicks JL; Epstein JI; Yegnasubramanian S; Nelson WG; De Marzo AM
Mod Pathol; 2008 Nov; 21(11):1337-44. PubMed ID: 18622385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
